MedPath

Investigation about the effect of VFEs on VF

Not Applicable
Conditions
Condition 1: voice disorders. Condition 2: Vocal fatigue.
Voice and resonance disorders
Dysphonia
R49.0
Registration Number
IRCT20220116053728N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
42
Inclusion Criteria

The participant must work at least three days a week that directly contacts customers.
The participant must have at least 1.5 hours of speaking on each working day.
The participant should often use their maternal language to communicate with customers.
The participant often uses a mask in the working environment.

Exclusion Criteria

The applicant has a history of neurological, respiratory, head and neck, pharyngeal/laryngeal, allergies, asthma, reflux, and/or hearing system diseases or surgeries.
The applicant have a vocal training in the last six months ago.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Scores in the three sections of the vocal fatigue index (VFI). Timepoint: On the day of training and one day before the start of training (in the intervention group) or one day before the start of the 14 days in the control group (pre-term data); One day after completing the 14-day training period (in the intervention group) or the waiting period in the control group (post-term data). Method of measurement: Persian version of Vocal Fatigue Index.
Secondary Outcome Measures
NameTimeMethod
Total score of the voice handicap index (VHI). Timepoint: On the day of training and one day before the start of training (in the intervention group) or one day before the start of the 14 days in the control group (pre-term data); One day after completing the 14-day training period (in the intervention group) or the waiting period in the control group (post-term data). Method of measurement: Persian version of Voice Handicap Index.
© Copyright 2025. All Rights Reserved by MedPath